ELIZABETH GOLDBERG: Open Payments
NPI 1669647533 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 21 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $341 · 2025 $489
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| ABBVIE INC. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $15 |
Products named: FANAPT, CAPLYTA, VRAYLAR, Auvelity, Jornay PM, REXULTI, TRINTELLIX, Adzenys XR-ODT.
Industry payments across FL — which companies pay providers there.
